Target intelligence / Profile preview

DIX domain-containing protein 1 (DIXDC1)

Target
DIXDC1
Molecular classification
Other, Adapter/scaffolding protein, Wnt signaling component
01

Overview

DIX domain-containing protein 1 (DIXDC1) is an intracellular scaffolding protein that contains a DIX (Dishevelled–Axin) domain and serves as a positive regulator of canonical Wnt/β-catenin signaling[1][2][4]. It interacts with partner proteins, including Dishevelled and DISC1, to control cytoskeletal organization, centrosome function, neural progenitor proliferation, neuronal migration, and synaptic structure[1][3][5]. In vasculature, DIXDC1 regulates developmental and pathological angiogenesis by stabilizing VEGFR2 in response to Wnt signaling, facilitating vessel growth and repair under hypoxic conditions[2]. Dysregulation and upregulation of DIXDC1 have been linked to enhanced proliferation, invasion, and metastasis in multiple cancers via PI3K/AKT- and Wnt/β-catenin–dependent pathways[1]. Rare germline variants or loss of DIXDC1 disrupt neurodevelopmental signaling, contributing to increased risk for autism, schizophrenia, and bipolar disorder[3][5]. DIXDC1 is considered an important nodal protein integrating signal transduction pathways relevant to both developmental processes and disease pathogenesis[1][2][3][5].

Other names
DixinCCD1KIAA1735Coiled-coil-DIX1Coiled-coil protein DIX1
02

Mechanism of action

Inhibition or modulation of Wnt/β-catenin signaling by targeting pathway intermediates (e.g., GSK3 inhibition stabilizes β-catenin, lithium acts similarly—used in DIXDC1-deficient models to rescue signaling deficits)

03

Biological functions

Signal transductionCell cycle regulationNeuronal development (neurogenesis, migration, dendritic spine regulation)Cell proliferationCytoskeletal organizationAngiogenesisSynapse formation
04

Disease associations

Cancer (colorectal, non–small cell lung, gastric, pancreatic, acute myeloid leukemia, retinoblastoma, hepatocellular carcinoma, glioma, non–Hodgkin’s lymphoma)Neurodevelopmental and psychiatric disorders (autism spectrum disorder, schizophrenia, bipolar disorder, lissencephaly)Ischemic neuroprotectionPathological angiogenesis
05

Safety considerations

Off-target modulation of Wnt signaling may affect cell proliferation and developmental processesSuppressing DIXDC1 could impact neural development and angiogenesis
06

Interacting drugs

Lithium

1 more in the full profile.

07

Biomarkers

Altered DIXDC1 expression (prognostic in various cancers, risk marker in neurodevelopmental/psychiatric disease)VEGFR2 in pathological angiogenesis

Beyond the preview

Go deeper on DIX domain-containing protein 1 (DIXDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIX domain-containing protein 1 (DIXDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call